CMR Surgical

Positioning

CMR Surgical is a UK surgical-robotics maker whose Versius system has treated 45,000+ patients across 30+ countries (the second most-used soft-tissue platform per company claim), now launching commercially in the US in 2026 after a Versius Plus 510(k) clearance (December 2025). It has raised ~$1.1-1.4B total (a $200M+ round in April 2025 including Trinity Capital debt) and is pre-revenue in the US (UK/EU commercial). Its installed base is not disclosed.

Latest signals

• 15 Oct 2026Stryker invested $400 million in CMR Surgical.The Robot Report
• 15 Oct 2026Stryker became the exclusive U.S. sales agent for CMR Surgical’s Versius robotics portfolio.The Robot Report
• 14 Oct 2026Stryker received an exclusive option to acquire 100% of CMR Surgical.Robot News
• 14 Oct 2026Stryker invested approximately $400 million in CMR Surgical and secured exclusive U.S. distribution rights for Versius.Robot News
• 12 Oct 2026Stryker plans a $400 million investment in CMR Surgical with exclusive U.S. sales rights and an acquisition option.The AI Insider

39 signals name CMR Surgical. Members see all of them, filtered by topic, source and date.

Facts, with sources

• 22 Jul 2026Combining NVIDIA Isaac for Healthcare Medical Physics Simulation with CMR's clinical insights to create virtual training environmentsPartnership · CMR Surgical
• 1 Jul 2026Integration of Cosmos-H-Dreams with the Versius surgeon controller for real-time operation on the Versius platformPartnership · Hugging Face
• 1 Jul 2026Integration of Cosmos-H-Dreams with the Versius surgeon controller enabling real-time operation on the Versius platformPartnership · Hugging Face
• 26 Mar 202645000Deployment · CMR Surgical

73 facts on file. Members see all of them with the source link.

Scores, Robotics (of 10)

Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.

Categories